Financials
- Market Capitalization 8.17 B
- Employee 2 000
- Founded 1981
- CEO Tony J. Hunt
- Website www.repligen.com
- Headquarter Delaware, United States
- FIGI BBG000BS48J3
- Industry Medical Instruments & Supplies
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 772 | ALGN Align Technology, Inc. - Common Stock | 180.59 USD | +0.64% | -4.76% | +1.52% | -4.94% | 12.93 B USD | ||
| 831 | BAX Baxter International Inc. Common Stock | 22.59 USD | -0.13% | -1.91% | +7.01% | -21.43% | 11.67 B USD | ||
| 1035 | ATR AptarGroup, Inc. Common Stock | 124.90 USD | -0.51% | -1.51% | +5.72% | -20.69% | 7.97 B USD | ||
| 1211 | TFX Teleflex Incorporated Common Stock | 136.21 USD | +0.35% | +0.54% | +4.95% | +17.02% | 6.03 B USD |
Frequently asked questions about Repligen Corporation - Common Stock
What is the Repligen Corporation - Common Stock stock price today?
The current price of Repligen Corporation - Common Stock (RGEN) is 144.88. Over the past 24 hours, the stock has changed by +0.44%. Follow the RGEN chart for real-time price dynamics.
What is the stock ticker of Repligen Corporation - Common Stock?
Repligen Corporation - Common Stock trades under the ticker RGEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Repligen Corporation - Common Stock stock going up?
RGEN has changed by +0.21% over the last week, +8.35% over the last month, and -12.56% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Repligen Corporation - Common Stock net income for the last quarter?
Repligen Corporation - Common Stock reported net income of 8.33 M for the last quarter. The previous quarter showed 13.29 M, which means net income changed by -37.28%.
How many employees does Repligen Corporation - Common Stock have?
As of the latest available data, Repligen Corporation - Common Stock has 2 000 employees. Workforce size can provide additional context about the company's scale and operations.
What is Repligen Corporation - Common Stock EBITDA?
Repligen Corporation - Common Stock EBITDA is 30.11 M, and its EBITDA margin is 15.5%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Repligen Corporation - Common Stock stock?
You can buy Repligen Corporation - Common Stock (RGEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Repligen Corporation - Common Stock stock?
Investing in Repligen Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RGEN chart and related analysis on metatrader.com as part of your research.